ALLR compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ALLRAllarity Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ALLRAllarity Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ALLRAllarity Therapeutics, Inc.

0.98▼−9.26%

Mkt cap$17.2MRevenue$320,000Q4 FY25Revenue—

LLYELI Lilly & Co

1,394.00▼−1.69%

Regular sessionNov 5 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 5 '26

ALLRAllarity Therapeutics, Inc.

LLYELI Lilly & Co

0.98▼−9.26%

Price

1,394.00▼−1.69%

$17.2M

Mkt cap

$1.3T

Q4 FY25$320,000

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

ALLR0.98▼−9.26%vsLLY1,394.00▼−1.69%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ALLR: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ALLR 2

—Eisaiunlistedsupplier

—Chosa Oncologyunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

ALLR, solidLLY, dashed